Virbac SA (VIRP)
Euronext
Closed
Oct 8, 2026
Day's Range
314.0052 wk Range
297.00Overview - VIRP - Virbac SA
Key Statistics
Valuation
Enterprise Value
2.76B
P/E (Trailing)
‪16.55‬
P/E (Forward)
‪13.35‬
PEG Ratio
‪13.35‬
Price / Sales (TTM)
‪1.72‬
Price / Book
‪2.28‬
EV / EBITDA
‪9.47‬
Profitability
Profit Margin
‪10.42%‬
Operating Margin
‪18.08%‬
Return on Assets
‪7.59%‬
Return on Equity
‪13.61%‬
Ownership
Shares Outstanding
8.37M
Float
4.12M
Held by Insiders
‪50.81%‬
Held by Institutions
‪26.26%‬
Price stats
Beta
‪0.77‬
50-Day Avg
‪326.11‬
200-Day Avg
‪345.74‬
Dividends
Payout Ratio
‪7.80%‬
Analyst Consensus
8 analysts
Market Cap - VIRP - Virbac SA
Peers - VIRP - Virbac SA
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on Euronext.
- VIRPEuronextVirbac SA2.60BMarket Cap-2.58%52-week change16.56P/E (Trailing)‪10.42%‬Profit Margin
- SANEuronextSanofi SA84.97BMarket Cap-17.50%52-week change22.17P/E (Trailing)‪8.09%‬Profit Margin
- AMGEuronextAMG Critical Materials N.V.1.02BMarket Cap+0.28%52-week change359.25P/E (Trailing)‪0.29%‬Profit Margin
- TNGEuronextTransgene SA203.12MMarket Cap-57.53%52-week change-2.81P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - VIRP - Virbac SA
About
Virbac SA is a French pharmaceutical company exclusively dedicated to animal health, founded in 1968 by veterinarian Pierre-Richard Dick. It manufactures and markets a comprehensive portfolio of products including vaccines, antibiotics, parasiticides, anti-inflammatory drugs, dermatology solutions, dental care,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
